or
forgot password

    • cancer clinical trials in new mexico

    • S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer
    University of New Mexico Cancer Center - South
    Las Cruces, New Mexico 88011
    Breast Cancer
    Interferon Alfa-2b With or Without Bevacizumab in Treating Patients With Advanced Renal Cell Carcinoma (Kidney Cancer)
    Veterans Affairs Medical Center - Albuquerque

    Trial Locations
    Veterans Affairs Medical Center - Albuquerque
    University of New Mexico Cancer Research and Treatment Center
    Hematology-Oncology Associates, PC
    Lovelace Medical Center at Lovelace Sandia Health System
    New Mexico Cancer Care Associates
    Kidney Cancer
    S0226 Anastrozole With or Without Fulvestrant as First-Line Therapy in Postmenopausal Women With Metastatic Breast Cancer
    Lovelace Medical Center - Downtown

    Trial Locations
    Lovelace Medical Center - Downtown
    Hematology Oncology Associates, PC
    Presbyterian Cancer Treatment Center at Presbyterian Kaseman Hospital
    New Mexico Cancer Care Associates
    St. Vincent Cancer Center at St. Vincent Regional Medical Center
    Breast Cancer
    Comparison of Combination Chemotherapy Regimens With or Without Cetuximab in Treating Patients Who Have Undergone Surgery For Stage III Colon Cancer
    New Mexico Oncology Hematology Consultants

    Trial Locations
    New Mexico Oncology Hematology Consultants
    University of New Mexico
    Hematology Oncology Associates
    University of New Mexico at Lovelace Medical Center
    Presbyterian Kaseman Hospital
    Memorial Medical Center - Las Cruces
    New Mexico Cancer Care Associates
    Adenocarcinoma of the Colon, Stage III Colon Cancer
    Comparison of Radiation Therapy Regimens in Combination With Chemotherapy in Treating Young Patients With Newly Diagnosed Standard-Risk Medulloblastoma
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Brain Tumor, Central Nervous System Tumor
    DNA Variations in the Gene in Young Patients With Wilms' Tumor
    University of New Mexico Cancer Research and Treatment Center
    Albuquerque, New Mexico 87131
    Kidney Cancer
    Fluorouracil, Leucovorin, and Oxaliplatin With or Without Bevacizumab in Treating Patients Who Have Undergone Surgery for Stage II or Stage III Colon Cancer
    University of New Mexico Cancer Research and Treatment Center

    Trial Locations
    University of New Mexico Cancer Research and Treatment Center
    Lovelace Medical Center
    Hematology Oncology Associates, PC
    New Mexico Cancer Care Associates
    St. Vincent Regional Cancer Center
    Colorectal Cancer
    Combination Chemotherapy in Treating Young Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Leukemia
    Paclitaxel or Polyglutamate Paclitaxel or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial or Peritoneal Cancer or Fallopian Tube Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Southwest Gynecologic Oncology Associates Inc
    Memorial Medical Center - Las Cruces
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    A Companion Study for Patients Enrolled in Prior/Parent Ipilimumab Studies
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Melanoma
    Study of Long-Term Peg Intron Vs. Colchicine in Non-Responders.
    Northern New Mexico Gastroenterology
    Santa Fe, New Mexico 87505
    Hepatitis C Virus, Advanced Fibrosis, Cirrhosis
    A Study of ONTAK and CHOP in Newly Diagnosed, Peripheral T-Cell Lymphoma
    New Mexico Cancer Care Associates
    Santa Fe, New Mexico 87505-7670
    Lymphoma, T-Cell, Peripheral
    S-1 and Cisplatin as First-Line Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery
    University of New Mexico Cancer Research and Treatment Center

    Trial Locations
    University of New Mexico Cancer Research and Treatment Center
    Lovelace Medical Center
    Hematology Oncology Associates, PC
    New Mexico Cancer Care Associates
    Lung Cancer
    S-1 as Second-Line Therapy in Treating Patients With Metastatic Pancreatic Cancer
    Hematology Oncology Associates, PC

    Trial Locations
    Hematology Oncology Associates, PC
    New Mexico Cancer Care Associates
    Pancreatic Cancer
    Non-Invasive, Real-Time Technology for Diagnosis of Cervical Tissue
    University of New Mexico
    Albuquerque, New Mexico 87131
    Cervix, Cancer
    Study: Treatment of Relapsed Lymphoid Malignancies With an Anti-Angiogenic Approach
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Non-Hodgkin's Lymphoma, Cancer
    Colony-Stimulating Factor-1 (CSF-1) and Other Cytokines in Human Endometrial Carcinogenesis
    University of New Mexico
    Albuquerque, New Mexico 87131
    Uterine Neoplasms, Endometrial Neoplasms
    Combination of Oxaliplatin, Capecitabine, and Celecoxib With Concurrent Radiation for Rectal Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Hematology Oncology Associates
    New Mexico Cancer Care Associates
    Rectal Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    University of New Mexico Cancer Center
    Albuquerque, New Mexico 87131-5636
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal Cancer, or Fallopian Tube Cancer
    University of New Mexico

    Trial Locations
    University of New Mexico
    Southwest Gynecologic Oncology Associates Inc
    Brenner Tumor, Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma, Ovarian Mixed Epithelial Carcinoma, Ovarian Mucinous Cystadenocarcinoma, Ovarian Serous Cystadenocarcinoma, Ovarian Undifferentiated Adenocarcinoma, Primary Peritoneal Cavity Cancer, Stage III Ovarian Epithelial Cancer, Stage IV Ovarian Epithelial Cancer
    Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer
    University of New Mexico Cancer Center

    Trial Locations
    University of New Mexico Cancer Center
    Lovelace Medical Center - Downtown
    Radiation Oncology Associates, PA
    New Mexico Cancer Center
    Cancer Institute of New Mexico
    Prostate Cancer